CA2252573A1 - Composes heterocycliques - Google Patents

Composes heterocycliques Download PDF

Info

Publication number
CA2252573A1
CA2252573A1 CA002252573A CA2252573A CA2252573A1 CA 2252573 A1 CA2252573 A1 CA 2252573A1 CA 002252573 A CA002252573 A CA 002252573A CA 2252573 A CA2252573 A CA 2252573A CA 2252573 A1 CA2252573 A1 CA 2252573A1
Authority
CA
Canada
Prior art keywords
compound
compounds
group
azabicyclo
octyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002252573A
Other languages
English (en)
Inventor
Celia Ann Whitesitt
Richard Lee Simon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2252573A1 publication Critical patent/CA2252573A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne des composés hétérocycliques utiles pour la modulation d'un récepteur muscarinique.
CA002252573A 1996-04-23 1997-04-23 Composes heterocycliques Abandoned CA2252573A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1600596P 1996-04-23 1996-04-23
US60/016,005 1996-04-23
PCT/US1997/006678 WO1997039753A1 (fr) 1996-04-23 1997-04-23 Composes heterocycliques

Publications (1)

Publication Number Publication Date
CA2252573A1 true CA2252573A1 (fr) 1997-10-30

Family

ID=21774835

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002252573A Abandoned CA2252573A1 (fr) 1996-04-23 1997-04-23 Composes heterocycliques

Country Status (5)

Country Link
EP (1) EP0912183A4 (fr)
JP (1) JP2000509043A (fr)
AU (1) AU2738397A (fr)
CA (1) CA2252573A1 (fr)
WO (1) WO1997039753A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6737154B2 (en) * 1995-06-26 2004-05-18 3M Innovative Properties Company Multilayer polymer film with additional coatings or layers

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4555521A (en) * 1983-11-16 1985-11-26 Fmc Corporation Nematicidal 3-substituted-4-phenyl-1,2,5-thiadiazoles
US5043345A (en) * 1989-02-22 1991-08-27 Novo Nordisk A/S Piperidine compounds and their preparation and use
YU84791A (sh) * 1990-05-19 1994-06-10 Boehringer Ingelheim Kg. Biciklicni 1-aza-cikloalkalni
US5821370A (en) * 1994-10-24 1998-10-13 Eli Lilly And Company Heterocyclic compounds and their preparation and use
US5767280A (en) * 1995-06-01 1998-06-16 Eli Lilly And Company Process for making heterocyclic compounds
US6040442A (en) * 1995-06-01 2000-03-21 Eli Lilly And Company Process for preparing 1,2,5-thiadiazole containing ethers

Also Published As

Publication number Publication date
EP0912183A1 (fr) 1999-05-06
JP2000509043A (ja) 2000-07-18
AU2738397A (en) 1997-11-12
EP0912183A4 (fr) 1999-08-04
WO1997039753A1 (fr) 1997-10-30

Similar Documents

Publication Publication Date Title
JP3100160B2 (ja) 複素環式化合物、その調製方法およびその用途
EP0687266B1 (fr) Composes heterocycliques, preparation et utilisation
JP3100158B2 (ja) 複素環化合物及びそれらの製造及び用途
US5591755A (en) Pyridinyl thiadiazolyl compounds for treating glaucoma
EP0482939A1 (fr) Dérive d'isoquinolinone
JPH04295477A (ja) 緑内障処置のための置換ピラジン、ピリミジン、ピリダジン類
JPH11508540A (ja) 新規の置換アザ環式またはアザ二環式化合物
JPH09501659A (ja) 抗精神病方法
RU2075479C1 (ru) Арилоксиалкилгетероарил-8-азабицикло(3,2,1)октаны, способ их получения и гетероарил-8-азабицикло(3,2,1)октаны
EP1819709A1 (fr) Nouveaux derives aryliques diazabicycliques utilises en tant que ligands cholinergiques
CA2252573A1 (fr) Composes heterocycliques
US6117883A (en) Heterocyclic compounds
JPH11512444A (ja) 新規置換アザ環式またはアザ二環式化合物
US6187798B1 (en) Heterocyclic compounds
US6124312A (en) Heterocyclic compounds
US6281232B1 (en) Method of treating gastrointestinal motility disorders
JPH09507842A (ja) 消化管運動機能障害の治療方法
WO1999059995A1 (fr) Composes heterocycliques, leur preparation et leur utilisation
US20010031751A1 (en) Pharmaceuticals

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead